For a patient receiving continuous enteral nutrition, how long should the feed be paused before and after giving levothyroxine (thyroxine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Levothyroxine Administration with Continuous Enteral Feeds

For patients receiving continuous enteral nutrition, hold the feeding for at least 1 hour before resuming after levothyroxine administration, with the dose given as long as possible after the last feeding. 1

Guideline-Based Recommendations

The 2012 AACE/ATA clinical practice guidelines provide the most authoritative guidance on this specific clinical scenario. The guidelines explicitly state that crushed levothyroxine suspended in water should be given to patients receiving enteral feeding through nasogastric and other tubes, with feeding interrupted and doses given "as long as possible after feeding and at least 1 hour before resuming feeding." 1

Practical Implementation Algorithm:

  1. Stop the continuous enteral feed
  2. Wait as long as clinically feasible (the guideline emphasizes "as long as possible")
  3. Administer crushed levothyroxine suspended in water through the feeding tube
  4. Wait at least 1 hour before restarting the feed

Important Clinical Considerations

Minimum Hold Time

The guideline establishes 1 hour as the minimum hold time after levothyroxine administration before resuming feeds. However, the phrase "as long as possible after feeding" suggests that if you can hold the feed longer before giving the dose, absorption may be further optimized.

Alternative Approach

The guidelines acknowledge that intravenous levothyroxine should be considered when feeding cannot be interrupted, though this formulation is not universally available. 1 This provides an important backup option for critically ill patients where nutritional interruption is contraindicated.

Dosing Adjustment

When switching from oral to IV levothyroxine, initially give 70% or less of the usual oral dose since approximately 70% of oral levothyroxine is absorbed. 1

Supporting Research Evidence

Recent research supports more flexible approaches with newer formulations. A 2014 study found that liquid levothyroxine formulation can be administered directly through feeding tubes with only 30 minutes of feed interruption (before and after), maintaining adequate thyroid hormone levels. 2 However, this applies specifically to liquid formulations, not crushed tablets.

Common Pitfalls to Avoid:

  • Do not use the standard "30-60 minutes before breakfast" timing from the FDA label 3 for tube-fed patients—this guidance applies to oral intake with meals, not continuous enteral nutrition
  • Do not restart feeds immediately after levothyroxine administration, as this significantly impairs absorption
  • Do not assume tablet and liquid formulations have identical administration requirements—liquid formulations may allow shorter hold times 2
  • Monitor TSH levels more frequently in tube-fed patients, as absorption may be less predictable than in patients taking levothyroxine orally

Clinical Context

The rationale for holding feeds relates to levothyroxine's interaction with nutrients, particularly calcium, iron, fiber, and soy products found in enteral formulations, which significantly impair absorption. The 1-hour minimum represents a balance between optimizing drug absorption and maintaining adequate nutritional support in critically ill or dependent patients.

If using standard crushed tablet formulation: hold feeds for at least 1 hour after levothyroxine, with the dose given as far from the previous feeding as feasible. This remains the gold standard recommendation from the highest-quality guideline evidence available. 1

References

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.